![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/26/2904422/0/en/Greenwich-LifeSciences-Set-to-Join-Russell-2000-Index-Again.html
https://www.globenewswire.com/news-release/2024/06/14/2898847/0/en/Greenwich-LifeSciences-Announces-2-5-Million-Private-Placement.html
https://www.globenewswire.com//news-release/2024/03/13/2845250/0/en/Greenwich-LifeSciences-Extends-Lock-up-of-Directors-and-Officers-to-June-30-2025.html
https://www.globenewswire.com//news-release/2024/03/12/2844357/0/en/Greenwich-LifeSciences-Partners-with-GEICAM-in-Spain-Conducts-First-Site-Initiation-Visits-in-Europe.html
https://www.globenewswire.com//news-release/2024/02/27/2835781/0/en/Greenwich-LifeSciences-Flamingo-01-Phase-III-Clinical-Trial-Approved-to-Expand-into-Five-Largest-European-Countries.html
https://www.globenewswire.com//news-release/2024/02/22/2833450/0/en/Greenwich-LifeSciences-Flamingo-01-Manufacturing-Protocol-Accepted-by-European-Regulators.html
https://www.globenewswire.com//news-release/2024/02/14/2828914/0/en/Greenwich-LifeSciences-Provides-Update-on-Phase-III-Clinical-Trial-Flamingo-01.html
https://www.globenewswire.com//news-release/2023/11/21/2783835/0/en/Greenwich-LifeSciences-Extends-Lock-up-of-Directors-and-Officers-to-End-of-2024.html
https://www.marketscreener.com/quote/stock/GREENWICH-LIFESCIENCES-I-112902519/news/GREENWICH-LIFESCIENCES-INC-MANAGEMENT-S-DISCUSSION-AND-ANALYSIS-OF-FINANCIAL-CONDITION-AND-RESULT-42311513/